CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Date for Annual General and Special Meeting

Canopy Rivers (TSX: RIV) (OTC: CNPOF), today announced that it will hold its annual general and special meeting of shareholders of the company 10 a.m. EDT on September 24, 2020. The meeting will be held at the company’s offices; however, due to health concerns relating to the novel coronavirus and to comply with government and public health directives, Canopy Rivers is urging all shareholders to vote by proxy in advance of the meeting and is discouraging physical attendance. The meeting will be limited to registered shareholders and duly appointed proxyholders only. Shareholders who wish to access and ask questions at the meeting may do so by phone or audio-only webcast using the details provided in the update. In addition, an audio replay of the meeting will be available until October 24, 2020.

To view the full press release, visit http://cnw.fm/5ANlr

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. Canopy Rivers believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise, and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders with exposure to specialized and disruptive cannabis companies. The company’s mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, Canopy Rivers is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) brings a pharmaceutical perspective to the cannabis industry, working to internationally recognized pharma-quality standards which result in products that are pure, trusted and precisely doseable for patients and end consumers. MediPharm Labs specializes in the creation and formulation of bulk active pharmaceutical ingredients (API’s) as well as the sale of white-labeled formulated finished products to a wide range of corporate partners in addition to its own proprietary, MediPharm Labs-branded products. MediPharm is currently working on the production of 60 different products and supplying API’s to clients in Australia, Europe, North America as well as the Asia-Pacific region.

Keith Strachan, President and Co-Founder at MediPharm Labs, will be participating in a Fireside Chat together with Tony Noto, Cannabis Editor at Benzinga.

To learn more about MediPharm Labs, visit https://www.medipharmlabs.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, covers dozens of investor conferences and online events as part of its ongoing service to the investment community. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of each featured session.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its many event collaborations in 2020, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Body and Mind Inc. (CSE: BAMM) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Body and Mind Inc.is a debt-free publicly traded US multi-state operator investing in high-quality medical and recreational cannabis cultivation, production and retail in California, Nevada, Ohio and Arkansas The company possesses a well-established distribution system comprised of long-term relationships with dispensaries throughout Nevada, as well as its own cultivation and production facilities. Subsequently, BAMM expanded into California through the ShowGrow dispensary in San Diego (60% owned by BaM) as well as the ShowGrow Long Beach dispensary while simultaneously creating Body and Mind branded products at a licensed California manufacturing facility. More recently, the BAMM has ventured into the states of Ohio and Arkansas, operating licensed medical dispensaries in both locations.

Trip Hoffman, President and Interim CEO of Body and Mind Inc, will be on the panel titled “Rolling Out: What’s next for Retailers in Adult-use Recreational”. With Michigan’s nascent recreational marijuana industry continuing to develop, the roll-out has had its fair share of challenges and successes. This panel will feature retailers who will share their experiences on how the roll-out is going, what the bestselling products are, as well as the role technology is playing to enhance their brand. The panel is also set to feature Erich Mauff, Co-Founder of Jushi; Howard Luckoff, CEO of New Standard; as well as Mark Passerini, the EVP of Operations at Mission Dispensaries. The talk will be moderated by Denise Pollicella, Founder and Managing Partner of the Cannabis Attorneys of Michigan.

To learn more about Body and Mind Inc., visit www.bamcannabis.com

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

SLANG Worldwide (CSE: SLNG) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

SLANG Worldwide (CSE: SLNG) is a consumer packaged goods company that owns, licenses and markets cannabis brands, serving the vaporizer, flower, concentrates, edibles and ingestibles categories. Featuring a robust portfolio of renowned brands distributed across over 2,600 retail stores in 12 US states, SLANG Worldwide sold over 4 million branded units in 2019, representing 250 million individual branded servings. Going forward, the company aims to focus its efforts on growing its presence within the states of Colorado and Oregon, expanding its partnerships in several other states, and further developing its product catalog – including vape brands ‘Firefly’ and ‘O.penVAPE,’ concentrates brand Bakked, and edibles brand District Edibles.

Chris Driessen, President and CEO of SLANG Worldwide, will be on the panel titled “When and Where to Apply Capital or Pull It Back”.

To learn more about SLANG Worldwide, visit https://www.slangww.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

4Front Ventures’ (CSE: FFNT) (OTCQX: FFNTF) Mission Dispensaries Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Mission Dispensaries is the retail subsidiary of 4Front Ventures (CSE: FFNT) (OTCQX: FFNTF), which currently owns, operates or manages cultivation and production facilities and retail facilities across 5 states with headquarters in Arizona. 4Front operates through 3 key subsidiaries, namely BrightLeaf Development, which oversees the cultivation, production and manufacturing aspect of 4Front’s business; Mission Dispensaries, which operates 4Front’s network of branded medical cannabis dispensaries and adult-use stores; as well as Pure Ratios’, which aims to combine cannabis into a wide-range of natural medicine products. Mission Dispensaries operates a chain of 13 medical cannabis dispensaries and adult-use stores across the states of Illinois, Maryland, Massachusetts, Pennsylvania, Arizona and Michigan.

Mark Passerini, Executive Vice President of Operations at Mission Dispensaries (retail subsidiary of 4Front), will be on the panel titled “Rolling Out: What’s next for Retailers in Adult-use Recreational”. With Michigan’s nascent recreational marijuana industry continuing to develop, the roll-out has had its fair share of challenges and successes. This panel will feature retailers who will share their experiences on how the roll-out is going, what the bestselling products are, as well as the role technology is playing to enhance their brand.

To learn more about Mission Dispensaries and 4Front, visit https://www.missiondispensaries.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Canopy Rivers (TSX: RIV) (OTC: CNPOF) is a venture capital firm specializing in investing and helping build out innovative companies from across the cannabis value chain. The company’s portfolio is wide-ranging, including companies focused on applying agricultural innovations that improve the potential of cannabis and hemp plants, the processing of cannabis and hemp into finished products, creating devices and tools used to enhance the cannabis consumption experience as well as software designed to streamline supply chain management and improve brand visibility. Canopy Rivers’ venture capital & portfolio operations team works directly with their portfolio companies to further identify opportunities for collaboration within the Canopy Rivers ecosystem.

Narbé Alexandrian, President and CEO of Canopy Rivers Inc., will be on the panel titled “Stop Chasing & Start Attracting the Right VCs”. Attendees will get the inside scoop on what some of the top venture capitalists look for when evaluating a company as their next potential investment.

To learn more about Canopy Rivers, visit https://www.canopyrivers.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Trulieve Cannabis (CSE: TRUL) (OTCQX: TCNNF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Trulieve Cannabis (CSE: TRUL) (OTCQX: TCNNF)is a leading medical cannabis company in the state of Florida, capturing a 51% share of Florida’s cannabis market. Operating a vertically-integrated “seed-to-sale” model, Trulieve controls a network of 55 stores in Florida in addition to 57 stores nationwide through which it markets and distributes its wide range of more than 500 individual products. Over the past year, the company has taken steps to broaden its geographical footprint, announcing the purchases of licenses in California and Massachusetts while also opening a cannabis dispensary in the state of Connecticut.

Kim Rivers, CEO of Trulieve, will be delivering a keynote address during the Benzinga Cannabis Capital Conference.

To learn more about Trulieve Cannabis, visit https://www.trulieve.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Cresco Labs (CSE: CL) (OTCQX: CRLBF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Cresco Labs (CSE: CL) (OTCQX: CRLBF) is a vertically integrated cannabis company, with a wide range of operations spanning the cannabis value chain – including cultivation, manufacturing, extraction and packaging. Employing world-class agronomists, manufacturing experts and state-of-the-art agricultural equipment, Cresco Labs is present across 9 states, operating a chain of 15 production facilities and 22 wholly-owned cannabis dispensaries. In addition to its retail sale operations, Cresco Labs has created a wide-ranging distribution network, with the company’s products currently being retailed in more than 700 dispensaries spread across the United States. Cresco Labs has recently launched its first national retail brand, Sunnyside, which is designed to revolutionize and disrupt the existing cannabis retail experience.

Barrington Rutherford, Senior Vice President, Real Estate and Community Integration at Cresco Labs, will be on the panel titled “Social Equity Programs in Michigan”. Advocates and experts will join to discuss a number of different social equity initiatives, elaborate on how these would help promote diversity and inclusion within the Michigan market, as well as the challenges surrounding how these initiatives will be defined and implemented.

To learn more about Cresco Labs, visit https://www.crescolabs.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

420 with CNW – Coronavirus and Social Distancing Propels Cannabis Market

In March 2020, every other headline seemed to be about the run on toilet paper. But another product was silently being stockpiled in many American homes. Cannabis.

Orders for legal cannabis products surged in March in the 33 states where some form of cannabis is legal. The two-week spike was attributed to panic buying by consumers. After a bit of fluctuation, sales began to stabilize at the end of April. However, when those sales numbers stabilized, they were nearly 40% higher than at the same point in 2019.

The downturn hasn’t made a dent in demand, according to a recent whitepaper released at the end of July that reports 2020 industry growth is outpacing 2019 growth. Cannabis is proving to be recession-resistant with demand expected to remain steady in coming months.

Additionally, cannabis companies are on the rebound and retailers are now purchasing more than they were prior to the onset of the global pandemic. The whitepaper, a joint effort among three software companies, is entitled The State of the Cannabis Industry: 2020.

More good news for the industry is on the horizon. Researchers are now exploring how cannabis might be able to treat and prevent the Coronavirus. The study highlights how a particular strain of cannabis could potentially block COVID-19 from entering and infecting the human body. While this research is not yet peer reviewed or published, it is still an intriguing foray into another potentially revolutionizing benefit of the cannabis plant.

With all of this good news, cannabis companies are working harder than ever. As very few companies were prepared for the disruptions caused by the pandemic, and most businesses finding themselves ineligible for SBA loans or other forms of federal aid, cannabis companies will be forced to innovate and identify new ways of gaining competitive advantage in order to remain afloat. Over the long-term, however, the new strategies being formulated will forever change the landscape of the cannabis industry.

Companies are seeking innovative ways to maintain competitive advantage by leveraging the many technological and marketing opportunities available throughout the industry. This might explain why organizations such as marketing firm Sugarmade Inc. (OTCQB: SGMD) are seeing increased demand.

Sugarmade helps cannabis businesses strike the perfect chord among botany, brand and business to drive profitability. The company invests in operations and technologies with disruptive potential. For example, Sugarmade has found a unique approach to retail cannabis product distribution with its significant investment in BudCars Cannabis Delivery Service, which reported a 10% increase in total sales in just two weeks at the beginning of August.

“The Coronavirus pandemic is undeniably a game-changer for consumer behavior patterns that will likely have long-term implications as it drives new habits into place,” said Sugarmade CEO Jimmy Chan. “However, at this point, we have only scratched the surface of what is possible over the intermediate term for BudCars given that all of the growth we have booked so far has been exclusively about organic execution as we claim an increasing share of the market and drive enthusiastic repeat business from newly acquired customers.”

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – The Evolution and Importance of Cannabis Genetics

Today’s cannabis market is experiencing significant growth in and demand for product diversity. At the same time, producers want reliable and stable plant varieties to ensure their products provide consistent quality. Advancements in breeding programs, artificial selection, genetics optimization and data analytics are helping cannabis producers meet both needs.

Innovative new techniques are making it possible to achieve diversity and consistency. Producers are now able to engineer and cultivate a base product that is perfectly aligned with the specific goals and objectives of cannabis organizations throughout the industry.

Breeding programs begin with the development of a product profile. Several desired characteristics are identified and translated into goals for the final product. Next, generations are advanced and pedigrees with genetic variation are created.

In essence, breeding goals define what characteristics products should include and genetic variation defines how the organization will achieve those characteristics. It is then the breeder’s job to prepare and cultivate plant populations with the appropriate genetic makeup to produce the desired varieties.

Although artificial selection has been a common practice in farming for hundreds of years, there has been relatively little attention paid to genetic variety in the cannabis industry. That is rapidly changing. Today, artificial selection and marker-assisted breeding have enabled producers to customize and optimize the size, smell, color, texture and density of their crops.

The expansion of the medical cannabis market has highlighted the importance of artificial selection. Specific medicinal needs require particular strains of cannabis that produce a variety of outcomes. Artificial selection is making this increasingly possible.

The evolving diversity of cannabis strains is essentially creating a new field within the cannabis industry. Licensed cultivators and researchers are working with product designers to optimize and sometimes clone strains to satisfy requirements of unique use-cases.

There is a wealth of data being generated during this plant breeding process. Software solutions are assisting companies and universities by generating better yields, outcomes and plant resilience. Throughout each stage of the breeding process, from crossing to selections and evaluations, these platforms now provide cultivators and researchers the ability to track and trace data and to achieve specific breeding goals in a more efficient manner.

Breeders and variety testers can now leverage these solutions to load current and historical data, analyze data to uncover insightful trends and patterns, establish and design new breeding trials and fields, and transfer data from the field to the system using mobile applications.

One company taking advantage of these advancements is Pac Roots Cannabis Corp. (CSE: PACR), a cannabis producer committed to delivering the highest quality products by leveraging high-end selectively bred genetics.

The British Columbia cannabis company has partnered with experts at Phenome One, the provider of an intuitive software platform that makes sense of breeding data to help customers like Pac Roots manage their business more effectively. The partnership gives Pac Roots access to the Phenome One database, which houses more than 350 unique cannabis strains that have been carefully field-tested and artificially selected during a research period spanning more than 30 years.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.